KaloBios Ends Wild Day Up 400%; Down Slightly After-Hours

By: via Benzinga
KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) shares ended today's session higher by $8.23 or nearly 400 percent. Martin Shkreli is ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.